KR880701700A - 알파-할로겐화된 디카르복실산을 함유하는 약제 - Google Patents

알파-할로겐화된 디카르복실산을 함유하는 약제

Info

Publication number
KR880701700A
KR880701700A KR1019880700646A KR880700646A KR880701700A KR 880701700 A KR880701700 A KR 880701700A KR 1019880700646 A KR1019880700646 A KR 1019880700646A KR 880700646 A KR880700646 A KR 880700646A KR 880701700 A KR880701700 A KR 880701700A
Authority
KR
South Korea
Prior art keywords
formula
compound
amides
esters
dicarboxylic acids
Prior art date
Application number
KR1019880700646A
Other languages
English (en)
Other versions
KR960003807B1 (ko
Inventor
야곱 바르-타나
요엘리트 마이그론
조카난 블럼
브룬노 드렉크만
요한네스 필
Original Assignee
마르틴 요트.루츠
에피스 에스. 아.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 마르틴 요트.루츠, 에피스 에스. 아. filed Critical 마르틴 요트.루츠
Publication of KR880701700A publication Critical patent/KR880701700A/ko
Application granted granted Critical
Publication of KR960003807B1 publication Critical patent/KR960003807B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
    • C07C55/02—Dicarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
    • C07C55/02—Dicarboxylic acids
    • C07C55/21—Dicarboxylic acids containing twelve carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
    • C07C55/32—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms containing halogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

내용 없음

Description

알파-할로겐화된 디카르복실산을 함유하는 약제
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (6)

  1. 다음 일반식(I)의 알파 할로겐화된 디카르복실산, 이들의 약리학적으로 수용가능한 염, 에스테르 또는 아미드를 함유하는 약제:
    상기식에서 Hal은 염소, 브롬 및 불소를 나타내고, R은 수소 및 Hal을 나타내고, m 은 4내지 16사이의 정수를 나타낸다.
  2. 지방과다증, 과지방혈증 또는 당뇨벙의 치료를 위한 제1항에 따른 화합물의 용도.
  3. 지방과다증, 과지방혈증 또는 당뇨벙의 치료 약제를 제조하기위한 제1항에 따른 화합물의 용도.
  4. 다음 일반식(I′)의 알파-할로겐화된 디카르복실산, 이들의 염, 에스테르 및 이들의 아미드(단, 화합물 2,22-디클로로도데칸-1, 12-디오산, 2,11-디브로모도데칸-1, 12-디오산 디에틸 에스테르, 2,2,15,15-테트라브로모핵사데칸-1,16-디오산 디메틸에스테르 및 N,N′-디메틸-2,2,15,15-테트라브로모헥사데칸 디아미드는 제외함):
    상기식에서 Hal은 염소, 브롬 및 불소를 나타내고, R은 수소 및 Hal을 나타내고, n 은 8내지 16사이의 수를 나타낸다.
  5. 다음 일반식(I′)의 알파-할로겐화된 디카르복실산, 이들의 염, 에스테르 및 이들의 아미드(단, 화합물 2,11-디클로로데칸-1, 12-디오산, 2,11-디브로모도데칸-1, 12-디오산 디에틸에스테르, 2,2,15,15-테트라브로모핵사데칸-1,16-디오산 디메틸에스테르 및 N,N′-디메틸-2,2,15,15-테트라브로모헥사데칸 디아미드는 제외함)의 제조방법에 있어서, 방법 a) 다음 일반식(II)의 디카르복실산 또는 이들의 유도체를 적당한 할로겐화제와 반응시켜 해당하는 알파-, 알파′-디할로디카르복실 산을 얻거나, 또는 방법 b) b1) R이 수소를 나타내는 일반식(I′)의 알파-, 오메가-디카르복실산을 염기와 반응시킨후 할로겐화제와 반응시켜 R이 할로겐을 나타내는 일반식(I′)의 화합물로 전환하거나, 또는 b2) 다음 일반식(III)의 화합물 또는 염기성 조건하의 이들의 유도체를 다음 일반식(IV)와 반응시켜 R이 할로겐원자인 일반식(I′)의 화합물을 얻고, 그리고 이어서 임의로, 이렇게 얻은 일반식(I′)의 화합물을 일반식(I′)의 다른 화합물로 전환하고, 마찬가지로, 얻어진 에스테르, 아미드 또는 염을 유리산으로 전환하거나 또는 유리산을 약리학적으로 수용가능한 염, 에스테르 및 아미드로 전환하는 것을 특징으로 하는 일반식(I′)의 알파-할로겐화된 디카르복실 산, 이들의 염, 에스테르 및 아미드의 제조방법:
    상기식에서 Hal은 염소, 브롬 및 불소를 나타내고, R은 수소 및 Hal을 나타내고, n 은 8내지 16사이의 수를 나타내고, Y는 쉽게 분리되는 잔기를 나타낸다.
  6. 2,2,13,13-테트라클로로테트라데칸-1,4-디오 산.
    ※참고사항:최초출원 내용에 의하여 공개하는 것임.
KR1019880700646A 1986-10-08 1987-10-05 알파-할로 겐화된 디카르복실산을 함유하는 지질저하 또는 항당뇨성 약제 조성물 KR960003807B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DEP3634356.0 1986-10-08
DE19863634356 DE3634356A1 (de) 1986-10-08 1986-10-08 Arzneimittel enthaltend alpha-halogenierte dicarbonsaeuren
PCT/CH1987/000133 WO1988002746A1 (en) 1986-10-08 1987-10-05 Medicaments containing alpha-halogenated dicarboxylic acids

Publications (2)

Publication Number Publication Date
KR880701700A true KR880701700A (ko) 1988-11-04
KR960003807B1 KR960003807B1 (ko) 1996-03-22

Family

ID=6311352

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019880700646A KR960003807B1 (ko) 1986-10-08 1987-10-05 알파-할로 겐화된 디카르복실산을 함유하는 지질저하 또는 항당뇨성 약제 조성물

Country Status (18)

Country Link
US (1) US4908385A (ko)
EP (1) EP0279978B1 (ko)
JP (1) JP2583545B2 (ko)
KR (1) KR960003807B1 (ko)
AU (1) AU603613B2 (ko)
CA (1) CA1311243C (ko)
DD (1) DD269145A5 (ko)
DE (2) DE3634356A1 (ko)
DK (1) DK298588A (ko)
ES (1) ES2037725T3 (ko)
FI (1) FI90860C (ko)
GR (1) GR3003697T3 (ko)
HU (1) HU199385B (ko)
IE (1) IE60236B1 (ko)
IL (1) IL84107A (ko)
PT (1) PT85882B (ko)
WO (1) WO1988002746A1 (ko)
ZA (1) ZA877444B (ko)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5214198A (en) * 1991-12-20 1993-05-25 American Cyanamid Company Process for the manufacture of halomaleic and halofumaric esters
US5602164A (en) * 1992-04-28 1997-02-11 Senyorina Ltd. Anti-obesity drugs
DE4224670A1 (de) * 1992-07-25 1994-01-27 Boehringer Mannheim Gmbh Verwendung von â,w-Dicarbonsäuren als Fibrinogensenker
DE4439947A1 (de) * 1994-11-09 1996-05-15 Boehringer Mannheim Gmbh 2,2-Dichloralkancarbonsäuren, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
IL119971A (en) 1997-01-07 2003-02-12 Yissum Res Dev Co Pharmaceutical compositions containing dicarboxylic acids and derivatives thereof and some novel dicarboxylic acids
DK1218542T3 (da) 1999-09-13 2004-08-02 Nugen Technologies Inc Fremgangsmåder og sammensætninger til lineær isotermisk amplifikation af polynukleotidsekvenser
US6692918B2 (en) * 1999-09-13 2004-02-17 Nugen Technologies, Inc. Methods and compositions for linear isothermal amplification of polynucleotide sequences
US7846733B2 (en) 2000-06-26 2010-12-07 Nugen Technologies, Inc. Methods and compositions for transcription-based nucleic acid amplification
DE60141087D1 (de) 2000-06-26 2010-03-04 Nugen Technologies Inc Methoden und zusammensetzungen zur auf transkription basierenden vervielfältigung von nukleinsäuren
EP1427847B1 (en) * 2000-12-13 2010-07-28 Nugen Technologies, Inc. Methods and compositions for generation of multiple copies of nucleic acid sequences and methods of detection thereof
JP2005508135A (ja) 2001-03-09 2005-03-31 ニューゲン テクノロジーズ， インコーポレイテッド Ｒｎａ配列の増幅のための方法および組成物
MXPA02012739A (es) 2001-03-09 2004-04-20 Nugen Technologies Inc Metodos y composiciones para amplificacion de secuencias de arn.
WO2004092418A2 (en) * 2003-04-14 2004-10-28 Nugen Technologies, Inc. Global amplification using a randomly primed composite primer
WO2007030759A2 (en) 2005-09-07 2007-03-15 Nugen Technologies, Inc. Improved nucleic acid amplification procedure
US20090203531A1 (en) * 2008-02-12 2009-08-13 Nurith Kurn Method for Archiving and Clonal Expansion
US7846666B2 (en) 2008-03-21 2010-12-07 Nugen Technologies, Inc. Methods of RNA amplification in the presence of DNA
WO2013084237A1 (en) 2011-12-08 2013-06-13 Syndromex Ltd. Deuterated tetramethyl dioic acids, compositions comprising them and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2971915A (en) * 1957-02-11 1961-02-14 Shell Oil Co Lubricating oil compositions
US3678102A (en) * 1970-09-11 1972-07-18 Ugine Kuhlmann {60 ,{60 ,{60 {40 ,{60 {40 -tetrasubstituted carboxylic diacids and process for their preparation
GB1350611A (en) * 1971-07-15 1974-04-18 Bp Chem Int Ltd Production of tetramethyl suberic acid
IL64542A0 (en) * 1981-12-15 1982-03-31 Yissum Res Dev Co Long-chain alpha,omega-dicarboxylic acids and derivatives thereof and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
AU603613B2 (en) 1990-11-22
FI90860B (fi) 1993-12-31
JP2583545B2 (ja) 1997-02-19
DE3775754D1 (de) 1992-02-13
DK298588D0 (da) 1988-06-01
IE60236B1 (en) 1994-06-15
WO1988002746A1 (en) 1988-04-21
PT85882B (pt) 1990-07-31
FI90860C (fi) 1994-04-11
GR3003697T3 (ko) 1993-03-16
DD269145A5 (de) 1989-06-21
CA1311243C (en) 1992-12-08
IE872679L (en) 1988-04-08
KR960003807B1 (ko) 1996-03-22
AU8027787A (en) 1988-05-06
EP0279978B1 (en) 1992-01-02
FI882669A0 (fi) 1988-06-06
PT85882A (de) 1987-11-01
DK298588A (da) 1988-06-01
JPH01501549A (ja) 1989-06-01
FI882669A (fi) 1988-06-06
DE3634356A1 (de) 1988-04-21
HUT46645A (en) 1988-11-28
ZA877444B (en) 1989-01-25
EP0279978A1 (en) 1988-08-31
IL84107A0 (en) 1988-03-31
ES2037725T3 (es) 1993-07-01
HU199385B (en) 1990-02-28
US4908385A (en) 1990-03-13
IL84107A (en) 1992-09-06

Similar Documents

Publication Publication Date Title
KR880701700A (ko) 알파-할로겐화된 디카르복실산을 함유하는 약제
KR840000528A (ko) 비스-트리아졸 유도체의 제조방법
ATE131173T1 (de) Fluorierte gallensäure-derivate, verfahren zu deren herstellung und pharmazeutische zusammensetzungen daraus.
DE19975059I2 (de) (2-Oxo-3-tetrahydrothienylcarbamoyl)-alkylthio-essigsäure, ihre Salze und Ester, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel.
KR860002453A (ko) 3-아미노-2-벤조일아크릴산 유도체의 제조방법
ES2105362T3 (es) Nuevos derivados de acidos quinolon- y naftiridoncarboxilicos.
KR840000463A (ko) 광학적으로 활성인 1-방향족 그룹으로 치환된-1- 알카논의 제조방법
ATE48835T1 (de) Chinolylglycinamidderivate, verfahren zu ihrer herstellung und therapeutische verwendung als psychotrope.
RU94026094A (ru) Применение феналкиламинов
KR920007995A (ko) 벤즈아미드 유도체
KR950031075A (ko) 새로운 3-페닐설포닐-3,7-디아자바이사이클로[3, 3, 1]노난-화합물을 함유하는 약제
NO175858C (no) Nye substituerte dicarboxylsyre-bis(3,5-dicarbamoyl)-2,4,6-trijod-anilider, og röntgenkontrastmidler inneholdende disse
ATE9224T1 (de) Azolverbindungen, verfahren zu ihrer herstellung und diese enthaltende fungizide.
ATE44142T1 (de) Isoxazol-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
ATE56707T1 (de) Imidazolverbindungen, verfahren zu deren herstellung und deren pharmazeutische zusammensetzungen.
KR910002891A (ko) 신규한 s-아데노실 메티오닌 디카르복실라제 억제제
ATE121723T1 (de) Phenylethanolamino- und phenylethanolaminomethyltetraline, verfahren zu deren herstellung zwischenprodukte davon und diese enthaltende pharmazeutische zusammensetzungen.
KR890014459A (ko) 4-할로-3-옥소-2-알콕시이미노부티르산 에스테르의 제조방법
KR890002111A (ko) 벤즈이미다졸 유도체, 그의 제법 및 치료에의 이용
KR830006183A (ko) 카르니틴의 알콕시-아실 유도체의 에스테르 제조방법
DE59108433D1 (de) Phenylethanolamine, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
KR880006223A (ko) 12- 할로겐화 포스콜린 유도체, 중간체 및 이의 제조방법, 및 약제로서의 이의 용도
NO903291L (no) Renin-hemmende aminooligohydroksyderivater.
ATE43594T1 (de) 3-alkoxy-2-(n-pyrrolidino)-n-pyridyl-n-furyl(od r thienyl)-methyl-propylamine, ihre herstellung und diese enthaltende pharmazeutische mittel.
KR920003970A (ko) 혈중 요산 함량의 강하 방법

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee